共 50 条
- [3] Treatment of Higher-Risk Myelodysplastic Syndromes After Failure of Hypomethylating Agents [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S56 - S59
- [5] Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (09): : 670 - 679
- [8] Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents [J]. Journal of Hematology & Oncology, 15